ProfileGDS4718 / 233297_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 1% 1% 1% 1% 1% 0% 1% 11% 1% 1% 8% 0% 1% 0% 0% 5% 1% 0% 1% 1% 2% 0% 0% 2% 1% 1% 2% 1% 0% 1% 1% 1% 1% 1% 1% 1% 0% 2% 3% 8% 1% 0% 1% 0% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.379071
GSM549102patient 115, normal, homogenized [OPG study]3.358761
GSM549104patient 119, normal, homogenized [OPG study]3.311951
GSM549108patient 138, normal, homogenized [OPG study]3.39191
GSM549119patient 077, normal, homogenized [OPG study]3.299581
GSM549133patient 032, cancer, homogenized [OPG study]3.179630
GSM549139patient 042, cancer, homogenized [OPG study]3.237591
GSM549099patient 107, normal, homogenized [OPG study]3.8092811
GSM549109patient 139, normal, homogenized [OPG study]3.274491
GSM549110patient 046, normal, homogenized [OPG study]3.3241
GSM549114patient 063, normal, homogenized [OPG study]3.683648
GSM549122patient 082, normal, homogenized [OPG study]3.156080
GSM549134patient 033, cancer, homogenized [OPG study]3.372661
GSM549136patient 036, cancer, homogenized [OPG study]3.079570
GSM549140patient 044, cancer, homogenized [OPG study]3.185420
GSM549111patient 047, normal, homogenized [OPG study]3.571685
GSM549113patient 057, normal, homogenized [OPG study]3.310011
GSM549132patient 031, cancer, homogenized [OPG study]3.188490
GSM549137patient 038, cancer, homogenized [OPG study]3.263391
GSM549142patient 047, cancer, homogenized [OPG study]3.328411
GSM549100patient 110, normal, homogenized [OPG study]3.440642
GSM549107patient 135, normal, homogenized [OPG study]3.152160
GSM549115patient 068, normal, homogenized [OPG study]3.173820
GSM549116patient 072, normal, homogenized [OPG study]3.441232
GSM549120patient 078, normal, homogenized [OPG study]3.239411
GSM549131patient 030, cancer, homogenized [OPG study]3.294241
GSM549118patient 074, normal, homogenized [OPG study]3.450522
GSM549129patient 027, cancer, homogenized [OPG study]3.319961
GSM549123patient 088, normal, homogenized [OPG study]3.184240
GSM549124patient 006, cancer, homogenized [OPG study]3.319591
GSM549126patient 015, cancer, homogenized [OPG study]3.286091
GSM549128patient 025, cancer, homogenized [OPG study]3.168061
GSM549103patient 117, normal, homogenized [OPG study]3.301021
GSM549117patient 073, normal, homogenized [OPG study]3.382171
GSM549138patient 041, cancer, homogenized [OPG study]3.207671
GSM549141patient 045, cancer, homogenized [OPG study]3.189611
GSM549130patient 028, cancer, homogenized [OPG study]3.069980
GSM549101patient 111, normal, homogenized [OPG study]3.397562
GSM549105patient 128, normal, homogenized [OPG study]3.504733
GSM549106patient 134, normal, homogenized [OPG study]3.65488
GSM549112patient 048, normal, homogenized [OPG study]3.379711
GSM549125patient 011, cancer, homogenized [OPG study]3.010520
GSM549127patient 024, cancer, homogenized [OPG study]3.218491
GSM549135patient 035, cancer, homogenized [OPG study]3.087270